Specific CCND1 c-terminal mutations involving Thr286 and Pro287 have been previously reported in endometrial cancer, such as T286I, P287T, P287S, which resulted in nuclear accumulation of cyclin D1, gain-of-function and cellular transformation [10][11]. The gene discussed is CCND1; the disease is endometrial cancer.